Mitesco, Inc.
For the period ended Jun 30, 2026. Filed Aug 17, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 17, 2026
MITIStored price and day change unavailable
Contents
Item 1. Consolidated Balance Sheets as of June 30, 2026, and December 31, 2025
CONSOLIDATED BALANCE SHEETS
| June 30, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| (Unaudited) | ||
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $7,984 | $100,857 |
| Accounts receivable, net | 37,600 | 27,600 |
| Unsecured advances | 55,000 | - |
| Prepaid expenses and other current assets | 941 | 3,651 |
| Total current assets | 101,525 | 132,108 |
| Total Assets | $101,525 | $132,108 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities | $4,053,707 | $4,027,183 |
| Accrued interest | 459,418 | 398,356 |
| Derivative liabilities | 822,696 | 399,160 |
| Deferred Revenue | - | 10,000 |
| Lease liability - operating leases, current | 99,477 | 99,477 |
| Notes payable, net of discounts | 639,416 | 639,416 |
| SBA loan payable | 354,034 | 367,801 |
| Convertible Notes Payable, Net | 709,372 | 503,341 |
| Other current liabilities | 96,136 | 96,136 |
| Preferred stock dividends payable | 32,314 | 26,314 |
| Legal settlements | 3,505,843 | 3,387,536 |
| Series A preferred stock liability, current | 11,619,154 | 9,447,335 |
| Total current liabilities | 22,391,567 | 19,402,055 |
| Series A preferred stock liability, non-current | 2,023,768 | 4,202,644 |
| Total liabilities | 24,415,335 | 23,604,699 |
| Commitments and contingencies (Note 12) | ||
| Stockholders’ deficit | ||
| Preferred stock, $0.01 par value, 100,000,000 shares authorized; 10,000,000 shares designated Series D; 10,000 shares designated as Series E; 140,000 shares designated as Series F; and 400,000 shares designated Series X: | ||
| Preferred stock, Series D, $0.01 par value, no shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | - | - |
| Preferred stock, Series F, $0.01 par value, no shares issued and outstanding as of June 30, 2026, and December 31, 205, respectively | - | - |
| Preferred stock, Series X, $0.01 par value, 51,703 and 42,103 shares issued and outstanding as of June 30, 2026, and December 31, 205, respectively | 517 | 421 |
| Common stock, $0.01 par value, 500,000,000 shares authorized, 20,940,597 and 15,093,055 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | 209,405 | 150,931 |
| Additional paid-in capital | 40,587,568 | 39,732,684 |
| Accumulated deficit | (65,111,300) | (63,356,627) |
| Total stockholders’ deficit | (24,313,810) | (23,472,591) |
| Total liabilities and stockholders’ deficit | $101,525 | $132,108 |
See accompanying notes to these unaudited consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.